Merck to build Gardasil 9 plant and add 425 jobs, but will cut 150 elsewhere
Merckís Gardasil is not just a moneymaker, it is a job creator. Just weeks after announcing a Virginia expansion to produce the vaccine and add 100 jobs, the drugmaker says it will build a new plant for Gardasil in North Carolina with 425 more.
Merckís news was not all positive, however. The drugmaker says that with the market shifting, it will stop production of the API for its varicella chickenpox vaccine in Durham and immediately lay off 150 workers.